info@seagull-health.com
SeagullHealth
语言:
search
new
Side effects caused by Elacestrant
500
Article source: Seagull Pharmacy
Jun 19, 2025

Elacestrant, the main component of Elacestrant, is mainly adapted to postmenopausal women or adult men with breast-related diseases. As a novel selective estrogen receptor degrader, it has shown significant efficacy in the treatment of advanced or metastatic breast diseases.

Side effects caused by Elacestrant

Any drug is inevitably accompanied by certain side effects, and Elacestrant is no exception. Understanding the side effects that Elacestrant may cause is crucial for patients.

Common side effects

The most common side effects of Elacestrant include musculoskeletal pain, nausea, decreased appetite, diarrhea, headache, constipation, abdominal pain, hot flashes, and indigestion.

Rare but serious side effects

Although not common, Elacestrant may also cause some serious side effects, such as liver dysfunction, hematologic toxicity (such as leukopenia, anemia, etc.), and cardiovascular system toxicity (such as hypertension, abnormal electrocardiogram, etc.).

Individual Differences

It is worth noting that the severity and frequency of side effects vary by individual. Some patients may experience only minor side effects, while others may face more serious challenges.

Understanding the side effects of Elacestrant helps patients better manage their health and seek medical help if necessary.

Methods to alleviate the side effects of Elacestrant

Patients don't have to worry too much about the side effects of Elacestrant. These side effects can be mitigated or alleviated through some effective strategies. If you have other questions about Elacestrant, you can also click for free online consultation

Symptom-based treatment

For mild to moderate side effects, such as nausea, vomiting, diarrhea, headache, etc., it can be relieved through symptomatic treatment. For example, use antiemetic drugs, antidiarrhea drugs or analgesic drugs.

Dose adjustment

If the side effects are severe enough to affect the patient's quality of life, you can consult with your doctor to adjust the dose of Elacestrant. Sometimes reducing dose or changing medication duration can reduce side effects.

Lifestyle adjustment

Maintaining good living habits and mindset can also help reduce side effects. Maintain adequate sleep, moderate exercise, a balanced diet, and avoid overwork.

Through symptomatic treatment, dosage adjustment and lifestyle adjustment, the side effects of Elacestrant can be effectively alleviated. Patients should work closely with doctors to develop personalized treatment plans.

Dietary structure of patients with Elacestrant

During the treatment of Elacestrant, the patient's dietary structure is equally important.

Balanced intake

Patients should ensure they consume enough nutrients such as protein, carbohydrates, fats, vitamins and minerals. A balanced diet can help boost immunity and relieve side effects such as fatigue.

Low-fat diet

Since Elacestrant may cause increased cholesterol and triglycerides, patients should try to avoid high-fat foods, such as fried foods, animal offal, etc.

Eat more fruits and vegetables

Vegetables and fruits are rich in vitamins and cellulose, which help promote digestion and enhance immunity. Patients can eat more foods rich in antioxidants, such as leafy green vegetables, citrus fruits, etc.

During the treatment of Elacestrant, patients should maintain a balanced diet, pay attention to nutrient intake, and try to avoid high-fat foods. A reasonable diet can not only provide the necessary nutritional support, but also help reduce the side effects of the medication.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Elacestrant(Orserdu)
Elacestrant(Orserdu)
Advanced or metastatic breast cancer that is ER-positive, HER2-negative, and...
WeChat Scan
Free Inquiry
Recommended Articles
Side effects of Elacestrant
Elacestrant is a novel estrogen receptor antagonist that provides an important therapeutic option for specific breast cancer patients. However, similar to other drugs, a series of side effects may occ...
What is the therapeutic effect of Elacestrant?
Elacestrant was developed and produced by Stemline, the United States, and was approved by the U.S. Food and Drug Administration (FDA) in January 2023, becoming the only oral selective estrogen recept...
How effective is Elacestrant?
In the treatment of breast diseases, the emergence of Elacestrant is of great significance. As an oral SERD, it is able to directly degrade estrogen receptors, thereby inhibiting the growth of disease...
Is Elacestrant(ORSERDU) effective?
The launch of the breast disease treatment drug ORSERDU/Elacestrant has brought new vitality to countless patients. This drug selectively degrades estrogen receptors and effectively blocks the growth ...
Tazemetostat's indications
Tazemetostat is a selective oral EZH2 (Enhancer of Zeste Homolog 2) inhibitor. EZH2 is an enzyme responsible for histone methylation in cells and has an important impact on cell proliferation and...
Tazemetostat(TAZVERIK) provides a new treatment path for patients with multiple refractory and recurrent diseases
Tazemetostat(TAZVERIK) is a novel EZH2 inhibitor that provides a new treatment pathway for patients with multiple refractory and recurrent diseases. It blocks the growth and spread of lesion cell...
Tazemetostat: effect and efficacy, usage and dosage, precautions
As a therapeutic drug, Tazemetostat mainly improves the condition by regulating the relevant functions in the body. Dosage adjustments need to be based on the doctor's advice to suit the pati...
How to use Tazemetostat?
Tazemetostat(TAZVERIK) is an innovative anti-disease drug that provides new therapeutic hope for patients with epithelioid sarcoma and relapsed or refractory follicular lymphoma.How to use Tazeme...
Related Articles
What are the Precautions for Taking Elacestrant (Orserdu)?
Elacestrant (Orserdu) is the first oral selective estrogen receptor degrader (SERD). It was approved by the FDA in 2023 for the treatment of advanced or metastatic breast cancer that is estrogen recep...
Side Effects of Elacestrant (Orserdu)
Elacestrant (Orserdu) is an estrogen receptor antagonist, primarily indicated for the treatment of estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, ESR1-mutat...
Dosage and Administration, Recommended Dose of Elacestrant (Orserdu)
Elacestrant (Orserdu) is an estrogen receptor antagonist, primarily indicated for the treatment of postmenopausal women or adult men with ER-positive, HER2-negative, ESR1-mutated advanced or metastati...
What Are the Indications of Elacestrant (Orserdu)?
Elacestrant (Orserdu) is a novel estrogen receptor antagonist. It was approved for marketing by the U.S. FDA in 2023, providing a precise treatment option for patients with advanced breast cancer harb...
What Are the Purchase Channels for Elacestrant (Orserdu)?
Elacestrant (Orserdu) is a novel estrogen receptor antagonist that plays an important role in the treatment of ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer.What Are th...
Side effects caused by Elacestrant
Elacestrant, the main component of Elacestrant, is mainly adapted to postmenopausal women or adult men with breast-related diseases. As a novel selective estrogen receptor degrader, it has shown signi...
Side effects of Elacestrant
Elacestrant is a novel estrogen receptor antagonist that provides an important therapeutic option for specific breast cancer patients. However, similar to other drugs, a series of side effects may occ...
What is the therapeutic effect of Elacestrant?
Elacestrant was developed and produced by Stemline, the United States, and was approved by the U.S. Food and Drug Administration (FDA) in January 2023, becoming the only oral selective estrogen recept...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved